chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA 4/24/2022,  9/24/2022,  12/22/2022,  3/9/2023,  1/11/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Cough, 102 fever, tired. Physician thought it was reaction to immunization.
Information has been received from a registered nurse concerning a 5 year old male patient who on 11/26/02 was vaccinated with a dose of varicella virus vaccine live. Concomitant vaccination administered on 11/29/102 included a dose of hepatitis B virus vaccine. The registered nurse reported that the patient was vaccinated from a different physician in another state. On 2/24/04, the patient developed chicken pox. The nurse described the patient's case of varicella as greater than 100 lesions. The registered nurse also mentioned that several other school classmates had it as well. The registered nurse did not have the lot or other information to offer. It was noted that no treatment was required and no product quality complaint was reported. The patient recovered. Unspecified medical attention was sought. No additional information has been requested.
Patient's mother described the appearance of welts on his back, chest, and legs within two hours of his vaccination. Evaluated him in my office approximately 8 hours after vaicination. He had discrete, fading erythematous macules on his trunk at the time. They had spontaneously resolved within 24 hours.
Patient was accompanied by her daughter to translate. Patient marked YES to the question if she had any allergies on her screen form and noted that she has allergic reactions to sulfur. Her daughter verbally told us she also has allergic reactions to shellfish. The daughter also noted that the sulfur allergy is about 10 years old and the shellfish allergy is 2 years. The daughter also stated that patient has carried an EPI pen for about 2 years and had her own pen with her.  We took her aside from the other patients and administered the vaccine with PA watching her. Approximately 10 minutes later, patient felt that her throat began to feel constricted and her tongue began to swell.  PA assessed her and decided that she should use her EPI pen. We moved her to an adjoining room (for privacy) and the daughter administered the EPI pen as patient stated that she did not know how to use it. The daughter also gave her mother 2 puffs of Ventolin inhaler.  PA exam her and she had a slight elevation in her pulse and course rales bilaterally. At this point, PA determined that we should call 911, which I did.  The swelling in throat and tongue began to diminish before the paramedics arrived. Paramedics assessed and decided she should be transported to hospital for full evaluation.
NEUROPATHY ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 2/17/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Admitted to hospital with difficulty breathing, fever, croupy cough, inspratory stridor, acute bronchitis.
A ringing in my ears started about 45 minutes after the shot. It has not gotten better.  It has made it difficult to fall asleep at night.
I noticed mild itching in my left arm about a week after the injection. That evening I saw that I had a red patch on my arm  a little larger than the palm of my hand. It is deminishing but not gone and itches mildly in the evening. I don't notice itching during the day.
Pt recvd a dose of vax 10SEP91 & 17SEP91 exp dysgeusia & vertigo; no tx given; vax series was discontinued p/1st inject; Asof 29OCT91 sx continue;
pt recv vax 24AUG98 5PM; Time of vax 10:40 24AUG T103, chills; given APAP;pt recv vax 25AUG 5AM T102, vomiting fluid given motrin;
Awoke 2 weeks after receiving the vaccine with redness, itching and soreness at the injection site. No new injuries. Evaluated by provider and diagnosed and treated for cellulitis. ***Hx of partial mastectomy and LN removal in left arm.
This spontaneous report was received from a physician refers to a 26 year old patient of unknown gender. On 04-AUG-2014 the patient was vaccinated with an expired M-M-R II (Lot # H011907, Expiration Date: 03-JUL-2014) (dose and route of administration were not reported). The patient had not reported or demonstrated any adverse effects. Additional information has been requested.
The parent called the clinic about 3:45 to report the patient had fever, headache, and abdominal pain with diarrhea, and body ache. The parent was advised to report to the urgent care for evaluation and follow up care.
Panic attacks, hand numbers, shortness of health, palpitations,tachycardia, dizziness sense of doom, low iron
Fussy, irritable, swelling on left hand side of face as well as hives which developed quickly. Rushed her to the hospital was administered BENADRYL and monitored for the remainder of the evening.
I woke up in a very heavy sweat and got up to use the bathroom. I felt unsteady. After washing my hands, I turned to the towel and vaguely remember falling to the floor. When I came to, I was too weak to get up. I laid there for 5 minutes before struggling to sit. After some time I was able to weakly return to bed and drank some rehydration tablets. My best guess was I had been drinking water but not replenishing my electrolytes.
Diarrhea Narrative: Employee reported feeling, weakness, cold, then hot and then had diarrhea. The employee feels like she has the flu. Has scratchy throat and voice hoarseness.
This spontaneous report was received from a Certified Medical Assistant via company representative, referring to a patient of unknown age and gender. The patient's pertinent medial history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with M-M-R II (anatomical route of vaccination, dose number, lot number, and expiration date were not provided). It was reported that the diluent (lot number and expiration date were not provided)  used to reconstitute the vaccine was expired. No adverse event was reported and no product quality issue was involved. This is one of several reports received from the same reporter. Additional information has been requested.
33 weeks Pregnant, no hx of reaction to previous covid vaccines. Received the updated Covid Modern Booster. Day of vaccine (Day 0) - swelling of arm, hardness/raised at injection site (about 2 x 1.5 inches) Day 1 - warm to touch at injection site,  red in color, tender to touch Day 2 - symptoms have pretty much subsided, besides still feeling raised/slight swelling. No longer warm/red
waited 8-10 weeks after his first moderna shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (waited 8-10 weeks after his first moderna shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (waited 8-10 weeks after his first moderna shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (waited 8-10 weeks after his first moderna shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter reported that they have a patient who has waited 8-10 weeks after his first moderna shot.
Temperature 95-96°F; Got the first shot of the vaccine and tested positive for COVID the same day; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got the first shot of the vaccine and tested positive for COVID the same day) and PYREXIA (Temperature 95-96°F) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced COVID-19 (Got the first shot of the vaccine and tested positive for COVID the same day). On an unknown date, the patient experienced PYREXIA (Temperature 95-96°F). At the time of the report, COVID-19 (Got the first shot of the vaccine and tested positive for COVID the same day) and PYREXIA (Temperature 95-96°F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 95-96 (Inconclusive) Temperature 95-96°F. On 26-Feb-2021, SARS-CoV-2 test: positive (Positive) tested positive for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Patient got the mRNA-1273 Moderna vaccine on 26-Feb-2021 and a few hours later got a swab test for COVID-19 because patient was scheduled for leg surgery on 01-Mar-2021.
Two and a half days after receiving the booster vaccination, my arm (near sight of injection) swelled up a lot (from shoulder to almost my elbow) and was extremely painful and was red in color and very hot to the touch. I've been icing my arm. I phoned my doctor, and I am waiting for her to call me back.
on 11/8/21 a pain in my neck (mid way to base of skull) started occurring throughout the day getting more painful. No muscle rub or pain medications seemed to help. By 11/12/21 my left ear was numb and numbness started moving across my face. I was able to smile and did not see dropping or anything. Numbness was to nose, lower left eye lid and going down neck. During this time I would get a severe sharp shooting pain behind my left ear at jaw line that would come and go. At times painful enough to have to stop what I was doing until it went away.  Was able to see a DR on 11/26/21 who ordered labs and an MRI afterwards referring me to a neurologist. Numbness did decrease in face and neck by 12/8/21 with about 10% of numbness left in ear. Did see neurologist on 12/13/21 who stated I had a small ischemic stroke. He also referred me to a cardiologist and put me on a ASA 81mg daily.
Vaccine given 7/5/2023  and on 7/6/2023 redness on upper thigh started. On 7/7/23 also had redness, swelling, discomfort and itching. Seem by provider and given Prednisolone orally for 5 days and Kenalog cream for 5 days. Also, advise could use ice.
Headache, chills, nausea, and 12hrs of severe diarrhea.
Noted to have urticarial rash on face, trunk and extremities about 7-8 hours after vaccinations. No fever, no respiratory distress no neurological defects noted. Pt given Zyrtec, Benadryl and Orapred after rash developed. Orapred made dramatic difference and rash resolving with it.
Patient was vaccinated at 1015am on 17 NOV23 in a sitting position (as listed above). Approximately 1 minute after receiving all 4 vaccinations he stated he felt lightheaded. The healthcare worker administering the vaccines went up to the patient and began laying him down while calling for help. Other workers began to assist, EMS was called, full set of vitals obtained. There was some myoclonic jerking that was witnessed however there was no tonic-clonic seizure-like activity seen. Patient came to immediately afterwards and was alert and oriented.  Patient did not have any preceding chest pain or difficulty breathing.  No history of similar symptoms in the past.  No known family history of cardiac dysrhythmias.  No bowel or bladder incontinence. Patient was in his normal baseline state of health without any preceding fevers, chest pain, difficulty breathing, respiratory symptoms, or GI symptoms. Patient was transported to the ER.  Patient did not sustain any trauma during the syncope to necessitate cross-sectional imaging of the head or C-spine. Suspect either vasovagal versus orthostatic but more likely the former and low suspicion for cardiogenic etiology.   follow-up with primary care provider as needed and return to ED for recurrent episodes of passing out or if there is persistent chest pains or difficulty breathing at rest.
10-17-11 - Patient states had increased swelling, redness, soreness, and hot to touch at injection site x 5 day. Was very painful. Patient did not report until 10-17-11 while calling to get info about future tetanus injections.
Initial and follow-up information has been received from the Merck Pregnancy Registry from an 18 year old female with a penicillin allergy who in May 2007 was vaccinated with a dose of GARDASIL. Concomitant therapy included hormonal contraceptives (unspecified). Subsequently the patient became pregnant. A pregnancy test was performed to confirm the patient's pregnancy. The patient's last menstrual period was on 23-MAY-2007. The patient's estimated date of delivery was 27-FEB-2007. The patient did not continue series of GARDASIL during her pregnancy. Unspecified medical attention was sought. At the time of the initial report, the patient was nine weeks gestation. Follow-up reported that on approximately 07-AUG-2007, the patient miscarried at 11 weeks. It was reported that had no procedures done and was doing "fine." At the time of the follow-up report, the patient was pregnant again (WAES #0805USA06056). Upon internal review, miscarried at 11 weeks was considered to be an other important medical event. Additional information has been requested.
This spontaneous report was received from a pharmacist refers to a 65 year old female patient. On 03-DEC-2013, the patient was vaccinated with PNEUMOVAX 23 (dose and frequency was not reported) lot # J005071, intramuscular for vaccination. On an unknown date in December 2013, the patient experienced red, hot, swollen, taughtness of kin which was painful and sore. On an unknown date in December 2013, the patient also experienced fever and chills. The patient sought medical attention and visited an unknown primary healthcare provider. The patient was prescribed with unspecified oral antibiotics. The outcome of the event red, hot, swollen, taughtness of skin which was painful and sore and fever and chills was reported as recovered. Additional information has been requested.
Reported to emergency department on 4/22/2004 with itching and redness to right deltoid.  Pulse Ox 99%, temp 98.0, pulse 112, resp 22, blood pressure 119/64 at ED visit.  Follow up appt. made with M.D. on 4/26/2004.
MIGRAINE; SEVERE BACK PAIN; SEVERE BODY PAIN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included fibromyalgia, obese, obstructive airways, and sleep apnea, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 180502 expiry: UNKNOWN) dose was not reported, administered on 16-MAR-2021 15:40 at left arm for prophylactic vaccination. No concomitant medications were reported. On 16-MAR-2021, the subject experienced migraine. On 16-MAR-2021, the subject experienced severe back pain. On 16-MAR-2021, the subject experienced severe body pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from migraine, severe back pain, and severe body pain. This report was non-serious.
MENSES; RASH ALL OVER BODY; PASSED OUT; VOMITING; ASTHMA ATTACK; MIGRAINE HEADACHE; FATIGUE; NUMBNESS AND TINGLING IN LOWER EXTREMITIES AND HANDS; PETEHIAE ALL OVER BODY; WAKE UP I ALL HOURS OF NIGHT; BRUISE EASILY; BURNING SENSATION IN LOWER  EXTREMITIES & HANDS; MUSCLE SPASMS IN LOWER EXTREMITIES; This spontaneous report received from a patient concerned a patient of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient have not had menses in plus 2 years and was fine until received vaccine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose was not reported, 1 total administered on 14-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 14-AUG-2021, 15-20 minutes after receiving the vaccination, had an asthma attack with a migraine headache, on 15-AUG-2021, had vomiting and passed out. On 17-AUG-2021, had rash all over body & menses, Haven't had menses in 2 plus years and had seen gynecologist and all tests came negative. Petechiae all over the body. Numbness and tingling in lower extremities and hands with burning sensation and Wake up all hours of night with muscle spasms in lower extremities and bruise easily, Fatigue easily. This all occurred within days of receiving the vaccine. And patient was fine until getting the vaccine. The patient reported that, ultimately have untoward life long side effects from the product that is horrific. Laboratory data (dates unspecified) included: Investigation (NR: not provided) negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the asthma attack, migraine headache, vomiting, passed out, rash all over body, menses, petechiae all over body, numbness and tingling in lower extremities and hands, muscle spasms in lower extremities, bruise easily, fatigue and burning sensation in lower extremities & hands was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211031961-Covid-19 vaccine ad26.cov2.s Passed out. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
following day,2nd shot. i had chills,no fever,spine hurts along my whole back, exhausted .
Shortly after receiving the J&J Covid injection my blood pressure increased 70psi on the high side and 50 on the low side.  My pressure had been stabile for years and I've never needed BP medication.  I now have to take BP meds to control my BP despite my weight being lower, my resting heart rate being 53 and exercising 5 times a week.
Information has been received from a registered nurse, concerning a 50 year old female with hearing loss (16-AUG-2007), a facial nerve disorder, Lyme disease with arthritis, pruritus, multiple allergic reactions to antibiotics including tetracycline, CECLOR and KEFLEX, and multiple drug hypersensitivities including morphine, and propoxyphene and DARVOCET, who on 21-FEB-2007 was vaccinated with the first dose, 0.5 ml, IM in the left deltoid, of GARDASIL (lot #656372/0243U). Concomitant therapy included INDERAL, MINOCIN, TRILISATE TABLETS/LIQUID), DIAMOX and MIDRIN. On 05-APR-2007 the patient was hospitalized after she developed facial palsy. The nurse reported that on 09-APR-2007, the patient called the office to report her condition. The patient remained hospitalized until 16-APR-2007, and on that day she called the office, and stated that she "had a possible diagnosis of Guillian Barre syndrome." The patient reported she believed that Gardasil caused her condition, and had requested a human papilloma virus antibody test. The reporter considered the event of facial palsy and possible Guillian Barre syndrome to be an other significant medical event. Additional information has been requested.   5/27/08 Received additional medical records from FDA which patient had provided & include consultant records from out of state clinic neurologist on 10/02/2007 diagnosing w/GBS Miller Fisher variant.  Tx w/IVIG w /some improvement but residual facial deficits.   Patient also submitted own VAERS report.  5/29/07 Received hospital medical records which reveal patient experienced sudden inability to speak, close eyelids or move face, and unable to swallow.  Admitted 4/4-4/16/07.  Neuro & Psych consults done.  Treated w/IV antibiotics in hospital & continued on IV antibiotics at home FINAL DX: cerebral Lyme disease. 1/21/2010 Many permanent, significant, severe and disabling neurological and other-including whole body-symptoms from Guillian Barre Syndrome.
Pain at the injection site; This is a spontaneous report from a contactable consumer (patient) via the Pfizer-sponsored Program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on an unspecified date (reported as "Monday"), at single dose, for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she took her 1st dose of vaccine on Monday (unknown date) and had a side effect which was pain at the injection site. The outcome of the event was unknown.  Information about the lot/batch number has been requested.
After receiving at age 12 Months MMR #1, Varicelle #1, PCV13 #4, Hep A #1, the next day she started with fever 101 F and a Maculopapular rash erythematous in trunk that spread to arms, legs and face and also had a big Macular erythematous Rash (about 4 cm diameter) where PCV13 vaccine was placed. Fever x 2 days. Rash is improving, resolving.
Syncope approx 15 seconds. VS repeated in 10 min intervals BP stabilized at 122/68 HR 86 RR 20, oral fluids given to pt.
Pt reported chest pain "medium" nothing makes it better or worse. Vitals: 97/56, 93, 18 Pt given water and rest in supine position.  Previous 1st dose was without incident.  VVS.  D/w mother to call PCP if worsens. Physical exam unremarkable. Pt ambulated w/o distress and pain improved.  Pt stable and release from the vaccination site @17:30.  Accompanied by  mother.  Rec. f/u w/ PCP.
Janssen COVID-19 Vaccine EUA: hospitalized for COVID-19 infection (pneumonia) and subsequent acute hypoxemic respiratory failure. Intubated, proned, anticoagulated and received steroids and remdesivir. Recovered and discharged to home medically stable on oxygen.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 28-JUL-2014, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # J014235 and expiry date: 07-MAY-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
the PCV titers were very low; This is a spontaneous report received from contactable reporter(s) (Nurse) from medical information team.  A 3-year-old female patient received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), as dose  4, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Prevenar 13 (first dose), for immunization; Prevenar 13 (second dose), for immunization; Prevenar 13 (third dose), for immunization. The following information was reported: ANTIBODY TEST ABNORMAL (non-serious), outcome "unknown", described as "the PCV titers were very low".  The information on the batch/lot number for pneumococcal 13-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
Approximately 36 hours status post vaccination this infant suffered a 15 minute of hypotonia and pallor with unresponsiveness. Spontaneous resolution, no fever, no cough, no rhinorrhea.
t103 4 days, nausea & rash; pt had pred inject the day a/;